Ascendis Pharma A/S Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending December 31, 2024: USD 493.74 M

Ascendis Pharma A/S Net Cash Used Provided By Financing Activities is USD 493.74 M for the Trailing 12 Months (TTM) ending December 31, 2024, a 248.64% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • Ascendis Pharma A/S Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending December 31, 2023 was USD 141.62 M, a -67.75% change year over year.
  • Ascendis Pharma A/S Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending December 31, 2022 was USD 439.18 M, a 7.86% change year over year.
  • Ascendis Pharma A/S Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending December 31, 2021 was USD 407.18 M, a -42.36% change year over year.
  • Ascendis Pharma A/S Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending December 31, 2020 was USD 706.41 M, a 27.57% change year over year.
Key Data
Date Net Cash Used Provided By Financing Activities Depreciation And Amortization Dividends Paid Common Stock Issued